Medical Writing Trends in medical writing My First Medical Writing
front-coverpng

Volume 28, Issue 3 - Trends in medical writing

My First Medical Writing

Abstract

In this edition of My First Medical Writing, we welcome one of the first articles written by aspiring medical writer Mayya Sundukova. A physicist by training, Mayya pursued her PhD in neuroscience in SISSA, Italy, studying ion channels, and then became postdoc at the European Molecular Biology Laboratory in Rome, Italy, to study pain mechanisms and develop tools for neuroscientists. Now, she is exploring several career opportunities in academia and industry and developing her medical writing skills. It has been a pleasure working with her, seeing her grow dayby- day from constructive feedback, and now publishing her first article in Medical Writing.

References

  1. Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D. Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment. Eur J Pain. 2006; 10(4):287–333.
  2. Busse JW, Wang L, Kamaleldin M, et al. Opioids for chronic noncancer pain: A systematic review and meta-analysis. JAMA. 2018;320(23):2448–60.
  3. Shaikh SS, Nahorski MS, Woods CG. A third HSAN5 mutation disrupts the nerve growth factor furin cleavage site. Mol Pain. 2018;14:1744806918809223.
  4. Carvalho OP, Thornton GK, Hertecant J, Houlden H, Nicholas AK, Cox JJ, et al. A novel NGF mutation clarifies the molecular mechanism and extends the phenotypic spectrum of the HSAN5 neuropathy. J Med Genet. 2011;48:131–5.
  5. Einarsdottir E, Carlsson A, Minde J, Toolanen G, Svensson O, Solders G, et al. A mutation in the nerve growth factor beta gene (NGFB) causes loss of pain perception. Hum Mol Genet. 2004;13(8):799-805.
  6. Wood JN. Nerve growth factor and pain. N.Engl J Med. 2010;363(16):1572–3.
  7. Petty BG, Cornblath DR, Adornato BT, Chaudhry V, Flexner C, Wachsman M, et al. The effect of systemically administered recombinant human nerve growth factor in healthy human subjects. Ann Neurol. 1994;36(2):244–6.
  8. Cohen SP, Chang D, Hsu E, Hottinger D. Anti-nerve growth factor in pain management: current evidence. J Pain Res. 2016;9:373–83.
  9. Hochberg MC. Serious joint-related adverse events in randomized controlled trials of anti-nerve growth factor monoclonal antibodies. Osteoarthr Cartil. 2015;23 Suppl 1:S18–21.
  10. Nocchi L, Portulano C, Franciosa F, et al. Nerve growth factor-mediated photo - ablation of nociceptors reduces pain behavior in mice. Pain. Epub 2019 Jun 26.
  11. Mitsunaga M, Ogawa M, Kosaka N, Rosenblum LT, Choyke PL, Kobayashi H. Cancer cell-selective in vivo near infrared photoimmunotherapy targeting specific membrane molecules. Nat Med. 2011;17(12):1685–91.
  12. ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). Identifier: NCT02422979, Study of RM- 1929 and photoimmunotherapy in patients with recurrent head and neck cancer. 2015 [cited 2019 Aug 10]. Available from: https://clinicaltrials.gov/ct2/show/ NCT02422979.
  13. Gregory NS, Harris AL, Robinson CR, Dougherty PM, Fuchs PN, Sluka KA. An overview of animal models of pain: Disease models and outcome measures. J Pain. 2013;14:1255–69.
  14. Deuis JR, Dvorakova LS, Vetter I. Methods used to evaluate pain behaviors in rodents. Front Mol Neurosci. 2017;10:284.
  15. Nocchi L, Roy N, D’Attilia M, Dhandapani R, Maffei M, Traista A, et al. Interleukin- 31-mediated photoablation of pruritogenic epidermal neurons reduces itch-associated behaviours in mice. Nat Biomed Eng. 2019;3,114–25.

Search

Articles

Introduction
President's Message
EMWA News
Omics in silico and other trends in biomedical research: Impact on how and what we write
Catching the wave of lifestyle medicine
Artificial intelligence – will we be replaced by robots?
Now more than ever, scientists must speak up for science
When less is more: Medical writers as guardians of curated content
Predatory publishing – what medical communicators need to know
AMWA – EMWA – ISMPP Joint Position Statement on Predatory Publishing
How to combat medical misinformation with a sound content strategy
Subcontracting: Not for the faint of heart
Lay summaries and writing for patients: Where are we now and where are we going?
Clinical trial disclosure: Perspective from a medical writer for a contract research organisation
The 360° approach to authoring risk management plans
Trends in regulatory writing: A brief overview for aspiring medical writers
The medical writing landscape in China
News from the EMA
Regulatory Matters
Medical Communications and Writing for Patients
In the Bookstores
Getting Your Foot in the Door
Veterinary Medical Writing
Medical Devices
My First Medical Writing
Journal Watch
Good Writing Practice
Regulatory Public Disclosure
Out on Our Own

Member Login

Links

The Write Stuff Archive Contact Instructions for Authors Feature Article Template (Word) Journal Policies

Editoral Board

Editor-in-Chief:

Co-Editor:

Managing Editor

show all +

Associate Editors:

Section Editors:

Ad-hoc Editors:

  • Amy Whereat (SpeaktheSpeech Consulting, Asnieres sur Seine, France)

Editor Emeritus: